Fusion Pharmaceuticals FUSN 深 沪
等待开盘 07-22 09:30:00 美东时间
21.55
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 21.55
- 总市值 18.25亿
- 52周最高 21.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.31
- 委 比 0.00%
- 总股本 8469.26万
- 历史最高 21.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.98
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fusion Fuel Green PLC Announces Forthcoming Annual General Meeting
Fusion Fuel Green PLC announced the holding of its Annual General Meeting (AGM) on June 25, 2025, in Dublin. Shareholders are encouraged to review the AGM notice, which includes six board proposals. A key proposal is a reverse share split of Class A Ordinary Shares at a 4-to-1 to 40-to-1 ratio to meet Nasdaq's $1.00 per share minimum bid price requirement. CEO John-Paul Backwell emphasized the company's progress toward compliance and sustainabili...
06-04 12:00
RDC第一股登场，中国核药热潮揭开序幕
原标题：RDC第一股登场，中国核药热潮揭开序幕 中国创新药下一个爆点来了。 5月26日，先通医药申报港股上市，18A板块将迎来核药*股，这是一个值得关注的事件...
05-28 10:37
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.
03-14 02:52
AstraZeneca To Pump $570 Million Into Canada, Driving Expansion, Job Growth
AstraZeneca invests $570 million in Canada, expands facilities, and boosts R&D efforts, aiming to deliver 20 new medicines globally by 2030.
01-24 21:58
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW/ - ...
01-24 03:31
巨头重注核药赛道
（来源：医曜） 随着诺华三季报的披露，Pluvicto在今年前三季度中取得10.41亿美元的营收，成为全球首款销售额突破10亿美元的核药产品。Pluvicto的...
2024-11-06 07:28
西门子医疗拟2亿欧元收购诺华诊断业务，锁定放射性药物供应
8月25日，第一财经记者获悉，西门子医疗拟以约2亿欧元的价格收购诺华公司的诊断业务，该业务专门生产用于癌症扫描设备PET（正电子发射断层扫描）的放射性化学品。...
2024-08-25 20:01
生物医药上半年并购潮起
随着全球医药市场进入新的发展周期，市场不确定性因素增多，与此同时，创新生物科技公司正面临生存挑战。为了增加新技术、新产品管线的探索与布局，拥有资金优势的大药企开...
2024-07-10 05:00
生物医药上半年并购潮起：600亿美元投资盛宴，谁是最终赢家？
21世纪经济报道记者季媛媛 韩利明 上海报道 随着全球医药市场进入新的发展周期，市场不确定性因素增多，与此同时，创新生物科技公司正面临生存挑战。为了...
2024-07-09 19:39
AstraZeneca completes acquisition of Fusion Pharmaceuticals
AstraZeneca has completed its $2B acquisition of Fusion Pharmaceuticals. Late last month, Fusion shareholders overwhelmingly approved the deal. Fusion is focused on the development of radiopharmaceuti...
2024-06-05 05:19
